These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 35048999

  • 1. Corpus callosum volumetrics and clinical progression in early multiple sclerosis.
    Sotgiu MA, Piga G, Mazzarello V, Zarbo IR, Carta A, Saderi L, Sotgiu S, Conti M, Saba L, Crivelli P.
    Eur Rev Med Pharmacol Sci; 2022 Jan; 26(1):225-231. PubMed ID: 35048999
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. MRI-Defined Corpus Callosal Atrophy in Multiple Sclerosis: A Comparison of Volumetric Measurements, Corpus Callosum Area and Index.
    Granberg T, Bergendal G, Shams S, Aspelin P, Kristoffersen-Wiberg M, Fredrikson S, Martola J.
    J Neuroimaging; 2015 Jan; 25(6):996-1001. PubMed ID: 25786805
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis--a two-year longitudinal MRI/MRSI study of corpus callosum.
    Audoin B, Ibarrola D, Malikova I, Soulier E, Confort-Gouny S, Duong MV, Reuter F, Viout P, Ali-Chérif A, Cozzone PJ, Pelletier J, Ranjeva JP.
    Mult Scler; 2007 Jan; 13(1):41-51. PubMed ID: 17294610
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Functional correlates of callosal atrophy in relapsing-remitting multiple sclerosis patients. A preliminary MRI study.
    Barkhof FJ, Elton M, Lindeboom J, Tas MW, Schmidt WF, Hommes OR, Polman CH, Kok A, Valk J.
    J Neurol; 1998 Mar; 245(3):153-8. PubMed ID: 9553845
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Corpus callosum index: a practical method for long-term follow-up in multiple sclerosis.
    Figueira FF, Santos VS, Figueira GM, Silva AC.
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):931-5. PubMed ID: 18094848
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reliability of measuring regional callosal atrophy in neurodegenerative diseases.
    Van Schependom J, Jain S, Cambron M, Vanbinst AM, De Mey J, Smeets D, Nagels G.
    Neuroimage Clin; 2016 Dec; 12():825-831. PubMed ID: 27830115
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Midsagittal corpus callosum area and conversion to multiple sclerosis after clinically isolated syndrome: A multicentre Australian cohort study.
    Odenthal C, Simpson S, Oughton J, van der Mei I, Rose S, Fripp J, Lucas R, Taylor B, Dear K, Ponsonby AL, Coulthard A, Ausimmune AusLong Investigator Groups.
    J Med Imaging Radiat Oncol; 2017 Aug; 61(4):453-460. PubMed ID: 27995735
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Corpus callosum atrophy is strongly associated with cognitive impairment in multiple sclerosis: Results of a 17-year longitudinal study.
    Granberg T, Martola J, Bergendal G, Shams S, Damangir S, Aspelin P, Fredrikson S, Kristoffersen-Wiberg M.
    Mult Scler; 2015 Aug; 21(9):1151-8. PubMed ID: 25480866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.